While many of the foundational elements have remained the same, running successful clinical trials in ophthalmic research will require new skills and strategies to overcome the latest challenges:
- Sites overburdened with a backlog of studies from COVID-19 delays need help and guidance
- The management of staff retention during a period of unprecedented workplace attrition has become more important than ever and
- The permanently altered nature of the interactions between patients and medical professionals necessitates a flexible and adaptable research methodology
These new challenges demand a different way of thinking, and a set of solutions that ensure sites aren’t left to their own devices in changing and uncertain times. Sponsors, research organizations and investigators will have to create a new kind of community — one that allows for a new system of collaboration that can overcome the barriers towards successful ophthalmic research.
The industry’s most engaged players need to rethink the tried-and-true ways of working that have been relied upon in the past. Reinventing the typical site network to become a more closely collaborative, integrated community will benefit CRO’s, sponsors and investigators.
Join featured speaker Mike Watson for an engaging conversation about the value of holistic site partnerships and integrated patient solutions, and how they consistently keep ophthalmic research projects on time and within budget. The following are some of the ways in which their global ophthalmology site database, OraNetTM, has been able to increase trial feasibility and improve site performance:
- Stronger relationships reinforce the connection between sites and the research organization, pooling resources between investigators and contributing experts with unsurpassed foundational knowledge, expertise and experience
- Going beyond the traditional level of site support with integrated patient solutions accelerates recruitment and elevates on-site patient experience and data quality
Joining Mike Watson is Dr. Guruprasad Pattar, a practicing ophthalmologist and investigator on over 35 clinical trials. Learn from Dr. Pattar about how community-organized design and resource-sharing, including patient solutions from OraNetTM, provide a more supportive form of engagement conducive to successful clinical execution in his practice.
Register to learn about these innovative solutions in progress, and the ways in which they can contribute to improving healthcare for patients with ophthalmic conditions.
Speakers
Mike Watson, Vice President, OraNet™
As Vice President of OraNetTM, Ora’s strategic Ophthalmic Site Network and Patient Solutions department, Mike challenges his team to listen to the pain points of clinical sites and help solve any issues with creative solutions. As a result, the site network is uniquely positioned to help new, high-potential research sites clear the barriers to entry, while also maximizing the performance of sites that are already highly experienced. Since joining in April, Mike has helped double the size of the OraNetTM strategic Retina Site Network.
Prior to leading OraNetTM, Mike held the position of Senior Director of Clinical Operations for Ora’s Anterior Segment Division. In this role, Mike helped develop strategic relationships with over 40 ophthalmic practices for Ora’s site network, which later outperformed standard sites by up to 300 percent. Mike also led trial strategy for the department and oversaw execution of over 80 Phase 1-4 clinical trials.
Message Presenter
Dr. Guruprasad Pattar, MD, PhD, Comprehensive Ophthalmologist and Clinical Investigator
Following the completion of his ophthalmology residency and serving as the Chief Resident at Indiana University in 2015, Dr. Pattar has practiced as a Comprehensive Ophthalmologist at The Eye Care Institute in Louisville KY.
Dr. Pattar has specialized experience in cataract surgery with intraocular lens implantation, vitreo retinal treatment and care, glaucoma treatment and care and refractive surgery, including LASIK and PRK. He is board certified in ophthalmology, is a diplomate of the American Board of Ophthalmology and is a member of the American Academy of Ophthalmology.
During his time practicing at The Eye Care Institute, Dr. Pattar has also accumulated extensive experience in clinical research, authoring eight manuscripts and acting as the Principal Investigator, or sub-Investigator, on over 35 clinical trials in ophthalmology, contributing to the success of programs across a broad variety of indications.
Message Presenter
Mark Prussian, CEO of The Eye Care Institute and Butchertown Clinical Trials
Mark M. Prussian is a board-certified healthcare administrator and Chief Executive Officer of The Eye Care Institute and Butchertown Clinical Trials. He has served as CEO since 1995 and holds a tremendous sense of pride in the organizational growth during his tenure.
Mark holds a Bachelor of Science in Business Administration from Wayne State University and a Master of Business Administration from Webster University. Further, Prussian is a Certified Ophthalmology Executive and a Fellow of the American College of Healthcare Executives. Prussian co-authored One Eye or Two?: Insider Secrets to Help You Choose the Right LASIK Surgeon with John C. Meyer, MD. The book was the number one selling Kindle download in Medicine, and is offered for free as a patient education tool.
Prussian believes strongly in supporting his physicians with management support, enabling them to fully-devote their time to patient care & clinical research as a care option.
Message PresenterWho Should Attend?
- Anyone from new to experienced Ophthalmic Medical Professionals involved in clinical trials
- Clinical Trial Sponsors
- Start-up Clinical Development Leaders
- Those involved in the planning or execution of clinical trials for novel therapeutics
- Investigators and Medical Professionals executing trials in their practice
What You Will Learn
Attendees will learn:
- The demands of every clinical trial are different, but there are some challenges that are universal among all research trials — they require a new way of thinking about site networks and the relationships between investigators, research organizations, sponsors and patients
- How research organizations like Ora are changing the way they provide training, staff and patient solutions to projects, and in turn how they listen and consult with their investigator experts and local teams to together overcome these barriers and make every study a success
Xtalks Partner
Ora
Ora is the world’s leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 40 years, we have proudly helped our clients earn more than 50 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora’s pre-clinical and clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world’s most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.
Related Webinars
Navigating Industry Needs for Retina Therapy Clinical Research Success
Endpoints for Neuroprotection in Glaucoma Trials
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account